Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19

Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19

BackgroundCOVID-19 pathology is associated with exuberant inflammation, vascular damage, and activation of coagulation. In addition, complement activation has been described and is linked to disease pathology. However, few studies have been conducted in cancer patients.ObjectiveThis study examined c...

Full description

Bibliographic Details
Main Authors:	Ellinor I. Peerschke, Alisa Valentino, Rachel J. So, Scott Shulman, Ravinder
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Immunology
Subjects:	COVID-19 cancer complement thromboinflammation endothelial dysfunction
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.716361/full

Similar Items

“War to the knife” against thromboinflammation to protect endothelial function of COVID-19 patients
by: Gabriele Guglielmetti, et al.
Published: (2020-06-01)

Thromboinflammation and COVID-19: The Role of Exercise in the Prevention and Treatment
by: Helena Angelica Pereira Batatinha, et al.
Published: (2020-12-01)

The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
by: Miklós Lipcsey, et al.
Published: (2021-02-01)

Editorial: Platelets and Immune Responses During Thromboinflammation
by: Mirta Schattner, et al.
Published: (2020-05-01)

Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation
by: Stuart E. Lind
Published: (2021-01-01)

Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity
by: E. L. Nasonov, et al.
Published: (2020-09-01)

Platelets and Immune Responses during Thromboinflammation
Published: (2020)

The Role of CLEC-2 and Its Ligands in Thromboinflammation
by: Danyang Meng, et al.
Published: (2021-06-01)

Thromboinflammation Model-On-A-Chip by Whole Blood Microfluidics on Fixed Human Endothelium
by: Alexander Dupuy, et al.
Published: (2021-01-01)

Inflammation Induced by Platelet-Activating Viperid Snake Venoms: Perspectives on Thromboinflammation
by: Catarina Teixeira, et al.
Published: (2019-09-01)

The Role of Thromboinflammation in Delayed Cerebral Ischemia after Subarachnoid Hemorrhage
by: Devin W. McBride, et al.
Published: (2017-10-01)

Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19
by: Tatsuya Maruhashi, et al.
Published: (2021-05-01)

Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient
by: Thomas Menter, et al.
Published: (2021-07-01)

Vascular Interactions in Innate Immunity and Immunothrombosis: : Models of Endothelial Protection
by: Nordling, Sofia
Published: (2016)

Complement Activation in Kidneys of Patients With COVID-19
by: Frederick Pfister, et al.
Published: (2021-01-01)

Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 Infection
by: Simone Beretta, et al.
Published: (2021-02-01)

Insidious development of pulmonary embolism in asymptomatic patients with COVID-19: Two rare case-reports
by: Abdulrahman Alharthy, et al.
Published: (2020-01-01)

Pulmonary Thrombosis or Embolism in a Large Cohort of Hospitalized Patients With Covid-19
by: Natividad Benito, et al.
Published: (2020-08-01)

Platelets and Immune Responses During Thromboinflammation
by: Matthias Mezger, et al.
Published: (2019-07-01)

Platelets and Intravascular Immunity: Guardians of the Vascular Space During Bloodstream Infections and Sepsis
by: Braedon McDonald, et al.
Published: (2019-10-01)

Rationale for targeting complement in COVID‐19
by: Anastasia Polycarpou, et al.
Published: (2020-08-01)

Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease
by: Nicole Ng, et al.
Published: (2021-05-01)

Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option
by: Philip F. Stahel, et al.
Published: (2020-07-01)

The Antimicrobial Cathelicidin CRAMP Augments Platelet Activation during Psoriasis in Mice
by: Maryam F. Salamah, et al.
Published: (2020-09-01)

Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease
by: Nicholas R. Medjeral-Thomas, et al.
Published: (2021-04-01)

Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality
by: Federica Defendi, et al.
Published: (2021-09-01)

Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity
by: De Lorenzo A, et al.
Published: (2021-05-01)

Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH)
by: Judith Weiland, et al.
Published: (2021-05-01)

Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients
by: Paolo Macor, et al.
Published: (2021-08-01)

Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System
by: Courtney M. Barkoff, et al.
Published: (2021-12-01)

The Enigma of Endothelium in COVID-19
by: Savneet Kaur, et al.
Published: (2020-08-01)

Complement in the Pathophysiology of the Antiphospholipid Syndrome
by: Shruti Chaturvedi, et al.
Published: (2019-03-01)

Targeted Genotyping of MIS‐C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID‐19 Infection
by: Anagnostopoulos, A., et al.
Published: (2022)

A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?
by: Natella Maglakelidze, et al.
Published: (2020-05-01)

Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone
by: Chrysi Keskinidou, et al.
Published: (2021-07-01)

Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia?
by: E. Pierik, et al.
Published: (2020-01-01)

Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection
by: David S. Fedson, et al.
Published: (2020-03-01)

COVID‐19 hypothesis: Activated protein C for therapy of virus‐induced pathologic thromboinflammation
by: John H. Griffin, et al.
Published: (2020-05-01)

Complement Inhibition and COVID-19: The Story so Far
by: Fodil S, et al.
Published: (2021-07-01)

Transcriptional Regulation of Thrombin-Induced Endothelial VEGF Induction and Proangiogenic Response
by: Rusan Catar, et al.
Published: (2021-04-01)